WHO GRADE 2 GLIOMA
Clinical trials for WHO GRADE 2 GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE 2 GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE 2 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on recurrent brain tumors in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment for people whose high-grade glioma (a type of brain cancer) has returned after previous therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack a protein called GARP found on tumo…
Matched conditions: WHO GRADE 2 GLIOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New pill may replace chemo for kids with brain tumors
Disease control Recruiting nowThis study tests if a targeted drug called selumetinib works as well as standard chemotherapy (carboplatin and vincristine) for children and young adults with a slow-growing brain tumor called low-grade glioma. The tumor must not have a specific gene change (BRAFV600E) or be link…
Matched conditions: WHO GRADE 2 GLIOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC